Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
Merck reports mixed results in Q1 for Winrevair, Ohtuvayre
While Merck's Winrevair continued its upward trajectory, another of its growth products, Ohtuvayre, took a step back in the first quarter.
Kevin Dunleavy
Apr 30, 2026 11:40am
Merck bats for heart disease awareness
Apr 30, 2026 9:30am
Sun Pharma snaps up women's health leader Organon for $11.75B
Apr 27, 2026 11:06am
More than 60% of Americans using AI for medical information
Apr 23, 2026 9:45am
Merck goes with Google for AI push, strikes $1B enterprise deal
Apr 22, 2026 10:12am
FDA signs off on Merck's HIV combo pill Idvynso
Apr 21, 2026 3:26pm
